A severe oxaliplatin immune-induced syndrome after oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy (PIPAC)

Affiliations

Ezanno Anne-Cecile: Department of Gastrointestinal and Endocrine Surgery, Bégin Military Hospital, St Mandé, France
Malgras Brice: Department of Gastrointestinal and Endocrine Surgery, Bégin Military Hospital, St Mandé, France
Aoun Olivier: 46th Medical Unit, 5th Armed Forces Medical Center, Strasbourg, France
Delarge Amaury: Department of Acute Care Unit, Bégin Military Hospital, St Mandé, France
Doreille Alice: Department of Nephrology, Tenon Hospital, Paris, France
Pocard Marc: Department of Gastrointestinal and Cancerology, Pitié Salpetrière Hospital, Paris, France

Abstract

Oxaliplatin immune-induced syndrome (OIIS) was recently recognized as an uncommon complication of oxaliplatin therapy.